Tevogen Inc.
TVGNdata completeness 75%4 fiscal years on fileData notes: no data for concept 'revenue'; no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'pretaxIncome'
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Net income | $4.41M1 | −$60.5M2 | −$13.7M3 | −$26.3M3 |
| Operating cash flow | −$215,3954 | −$8.17M5 | −$12M6 | −$12.3M6 |
| Capital expenditure | — | $133,0007 | — | $64,4398 |
| Free cash flow (derived) | — | −$8.3M5 | — | −$12.4M6 |
| Total debt | $09 | — | — | — |
| Cash & equivalents | $129,18610 | $011 | $012 | $012 |
| Diluted shares | 2.4M | 24.8M | 2.9M | 3.3M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$24.8 of net worth that earned you −$79.15 and generated −$37.33 of cash last year.
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Share count is up 39% over 4 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2022-12-31 · accession 0001493152-24-016796 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-002426 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-014326 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-016796 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-002426 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-014326 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-002426 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2025-12-31 · accession 0001493152-26-014326 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-016796 (ShortTermBorrowings)
- 10-K · period ending 2022-12-31 · accession 0001410578-23-000698 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-002426 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-014326 (CashAndCashEquivalentsAtCarryingValue)